Target intelligence / Profile preview

Sweet almond β-glucosidase

Molecular classification
Enzyme, Glycoside hydrolase, Glycoside Hydrolase Family 1 (GH1)
01

Overview

Sweet almond β-glucosidase is an enzyme (EC 3.2.1.21) that catalyzes the hydrolysis of glycosidic bonds at the non-reducing end of β-D-glucosides and oligosaccharides, releasing glucose. It is a member of glycoside hydrolase family 1, featuring an α/β TIM barrel structure as inferred by homology modeling, and consists of 544 amino acids (molecular mass ~62 kDa for monomers, with the native form as a dimer). The enzyme is active over a wide pH range (optimum pH ~5.5), stable below 50°C, and utilized in carbohydrate structure analysis, plant biochemistry, and research into enzyme inhibition. Historically known as "emulsin," it serves as a model for studying glycosidase mechanisms and inhibitor development. In plants, it is relevant for cell wall modification, defense, and aroma release, but it is not directly targeted in therapeutic interventions.

Other names
Emulsinalmond β-glucosidasePrunus dulcis β-glucosidase
02

Mechanism of action

Competitive inhibition by cyclitol-azole compounds and gluco-azoles via mimicry of transition state or substrate conformation Mechanism-based irreversible inhibition by molecules forming stable enzyme intermediates

03

Biological functions

Hydrolysis of β-D-glucosidic bonds in glucosides and oligosaccharidesRelease of glucose from glycosidesPlant defenseAroma release in seeds and fruitsCarbohydrate processing and cell wall modification
04

Disease associations

Other (no direct disease implication; used in research on glycosidase inhibition and plant metabolism)
05

Interacting drugs

Azole-type β-glucosidase inhibitors (e.g., gluco-1H-imidazole, tetrazole, triazole derivatives)

1 more in the full profile.

Beyond the preview

Go deeper on Sweet almond β-glucosidase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sweet almond β-glucosidase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call